Viewing Study NCT01756261


Ignite Creation Date: 2025-12-24 @ 12:38 PM
Ignite Modification Date: 2026-05-29 @ 11:56 AM
Study NCT ID: NCT01756261
Status: COMPLETED
Last Update Posted: 2018-06-19
First Post: 2012-12-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: EYLEA [AMD-QOL(Age-Related Macular Degeneration-Quality of Life)] Post-marketing Surveillance in Japan
Sponsor: Bayer
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Macular Degeneration View
Keywords:

Keywords

Keyword Brief Keyword Text View
None EYLEA View
None Age-Related Macular Degeneration View
None QOL View